PHIBRO ANIMAL HEALTH CORP
For the period ended Nov 3, 2026. Filed Sep 18, 2026.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Nov 3, 2026 · Filed Sep 18, 2026
Contents
Cover page
Show cover page
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
(Amendment No. )
| | |
|---|---|
| Filed by the Registrant | ☒ |
| | |
| Filed by a Party other than the Registrant | ☐ |
| | |
| Check the appropriate box: | |
| | |
|---|---|
| ☐ | Preliminary Proxy Statement |
| | |
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| | |
| ☒ | Definitive Proxy Statement |
| | |
| ☐ | Definitive Additional Materials |
| | |
| ☐ | Soliciting Material under §240.14a-12 |
Phibro Animal Health Corporation
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
| | |
|---|---|
| ☒ | No fee required. |
| | |
| ☐ | Fee paid previously with preliminary materials. |
| | |
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
Phibro Animal Health Corporation
Glenpointe Centre East, 3rd** Floor**
300 Frank W. Burr Blvd., Suite 21
Teaneck, NJ 07666
NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
To be held at 9:00 A.M. Eastern Time on Tuesday, November 3, 2026
Dear Stockholder:
The 2026 Annual Meeting of Stockholders (the “Annual Meeting”) of Phibro Animal Health Corporation, a Delaware corporation (the “Company”), will be held at 9:00 A.M. Eastern Time on Tuesday, November 3, 2026, at the Company’s offices located at Glenpointe Centre East, 3 rd Floor, 300 Frank W. Burr Blvd., Suite 21, Teaneck, NJ 07666.
The purposes of the Annual Meeting, as more fully described in the accompanying proxy statement, are:
| 1. | to elect three Class I Directors to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified; |
| 2. | to ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending June 30, 2027; and |
| 3. | such other business as may properly come before the Annual Meeting. |
Our Board of Directors has fixed the close of business on September 11, 2026 (the “Record Date”) as the record date for the Annual Meeting. Only stockholders of record on the Record Date are entitled to notice of and to vote at the Annual Meeting. Further information regarding voting rights and the matters to be voted upon is presented in the accompanying proxy statement. You may vote in person at the Annual Meeting or by mailing a proxy card, if you have requested one.
This proxy statement and our annual report can be accessed directly at the following internet address: http://www.eqproxyportal.com/18918/annual. The Company will begin mailing its Notice of Internet Availability of Proxy Materials, proxy statement and the 2026 Annual Report on Form 10-K and proxy card/voting instruction form to stockholders on or about September 21, 2026.
Whether or not you plan to attend the Annual Meeting, we hope you will vote as soon as possible. We appreciate your continued support of Phibro Animal Health Corporation.
| | |
|---|---|
| | By order of the Board of Directors, |
| | |
| | Judith A. Weinstein |
| | Senior Vice President, General Counsel and |
| | Corporate Secretary |
| | September 18, 2026 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.